Intestinal Microbiome and Chronic Inflammatory Bowel Disease

Turku University Hospital

Overview

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

IBD patients to whom colonoscopy is performed will be recruited. Mucosal specimens from large intestine and terminal ileum will be collected as well as stool specimens. The microbiota will be analyzed at the microbiology laboratory and the results will be correlated with endoscopical, laboratory and histopathological findings.

Study Type

OBSERVATIONAL

Conditions

Colitis

Interventions

ObservationalOTHER

Blood, stool ja biopsy specimens

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * IBD Exclusion Criteria: * patient refusal to participate

Locations (1)

Turku University Hospital

Turku, Finland

Outcomes

Primary Outcomes

Change of microbiome in chronic inflammatory bowel disease

Time frame: 5 yrs

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.